3 Phoenix Bio-startups land in global Bio International 2019
Changing cancer from life-ending
diagnosis to treatable disease moves a step closer to reality if three
Phoenix-based bioscience startups find strategic partners or venture capital in
the BIO International Startup Stadium, June 3-6, in Philadelphia, Pennsylvania.
Hundreds of bioscience companies from
around the world vie for one of the 40 presentation slots in the stadium at the
world’s largest gathering of bioscience companies, bio venture capitalists and
scientists. Last year, more than 18,000 people attended the conference in
Boston. BIO, the Biotechnology Innovation Organization, hosts the world’s
largest global conferences for biotechnology and life sciences.
Phoenix bio startups Humabiologics,
LLC, Kalos Therapeutics and Ordinatrix LLC will make their pitches in BIO’s
Startup Stadium beginning Monday. The BIO 2019 Start-Up Stadium provides
early-stage companies the opportunity to access key members of the investment
community, venture philanthropy groups, strategic partners, and capital.
LLC, based in the Center for Entrepreneurial Innovation, stretches the gift
of human tissue and organ donation by providing researchers with a stable
supply of high quality and affordable human-derived biomaterials for
translational regenerative therapies. Humabiologics is a regenerative medicine
startup founded by scientists and tissue industry experts.
Therapeutics is developing a non-toxic cancer treatment with little or no
side effects. The revolutionary technology leverages a natural, known mechanism
in the body to regular cell growth. It works by inhibiting the growth of cancer
LLC, provides research and development tools that aid in the development of
new drugs, diagnosis of disease and approaches to personalized medicine. The
company is an innovation spinoff from Arizona State University. It creates or
“prints” protein microarrays based on DNA. The protein arrays deliver more
functional, flexible and precise options for researchers.
Investor judges attend the
presentations, pepper company executives with questions. The judges seek
answers demonstrating the company has the scientific, human resource and
business acumen to succeed. After sessions, judges provide feedback for the
finalists. While any of the 40 presenting companies can find strategic
partners, grant opportunities or venture investors, five companies designated
as the winners receive other key benefits for fuel getting products to approval
To be considered qualified to take
the stage at the stadium, companies cannot have raised more than $10 million
since inception and employ fewer than 20 full-time employees. The firms must
have made a previous business pitch or participated in a capital competition.
No previous experience in BIO partnering is permitted.